X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11057) 11057
Magazine Article (60) 60
Newsletter (49) 49
Newspaper Article (41) 41
Book Chapter (35) 35
Publication (10) 10
Web Resource (7) 7
Book / eBook (5) 5
Book Review (4) 4
Dissertation (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9386) 9386
proton pump inhibitors (5754) 5754
male (4799) 4799
female (4556) 4556
proton pump inhibitors - therapeutic use (4053) 4053
middle aged (3599) 3599
gastroenterology & hepatology (3494) 3494
adult (2971) 2971
aged (2791) 2791
pharmacology & pharmacy (2432) 2432
treatment outcome (2187) 2187
omeprazole (2106) 2106
gastroesophageal reflux - drug therapy (2053) 2053
anti-ulcer agents - therapeutic use (1712) 1712
helicobacter infections - drug therapy (1632) 1632
helicobacter pylori (1447) 1447
risk factors (1415) 1415
proton pump inhibitor (1407) 1407
drug therapy, combination (1328) 1328
gastroesophageal reflux (1318) 1318
omeprazole - therapeutic use (1282) 1282
lansoprazole (1226) 1226
therapy (1129) 1129
anti-bacterial agents - therapeutic use (1125) 1125
proton pump inhibitors - adverse effects (1086) 1086
aged, 80 and over (1030) 1030
histamine h2 antagonists - therapeutic use (1010) 1010
medicine & public health (977) 977
risk (931) 931
animals (921) 921
retrospective studies (900) 900
medicine, general & internal (897) 897
care and treatment (878) 878
adolescent (848) 848
prospective studies (841) 841
proton pump inhibitors - administration & dosage (824) 824
double-blind (810) 810
2-pyridinylmethylsulfinylbenzimidazoles (809) 809
gastroesophageal-reflux disease (801) 801
management (790) 790
gastroesophageal reflux - diagnosis (784) 784
gastroesophageal reflux - complications (756) 756
omeprazole - analogs & derivatives (744) 744
disease (718) 718
young adult (711) 711
time factors (707) 707
gastroesophageal reflux disease (706) 706
health aspects (698) 698
hydrogen-ion concentration (689) 689
prevalence (688) 688
abridged index medicus (682) 682
gastroenterology (656) 656
enzyme inhibitors - therapeutic use (653) 653
proton-pump inhibitors (647) 647
drug therapy (640) 640
infection (638) 638
helicobacter pylori - drug effects (634) 634
rabeprazole (623) 623
drug interactions (622) 622
diagnosis (603) 603
surgery (602) 602
research (599) 599
internal medicine (587) 587
endoscopy (573) 573
pantoprazole (560) 560
esomeprazole (550) 550
symptoms (523) 523
anti-inflammatory agents, non-steroidal - adverse effects (522) 522
follow-up studies (511) 511
amoxicillin - therapeutic use (504) 504
oncology (501) 501
efficacy (499) 499
pharmacokinetics (495) 495
peptic ulcer - drug therapy (489) 489
analysis (485) 485
child (485) 485
esophagitis (479) 479
helicobacter infections - microbiology (475) 475
eradication (471) 471
clarithromycin - therapeutic use (464) 464
metaanalysis (459) 459
helicobacter infections - complications (448) 448
proton pump inhibitors - pharmacology (446) 446
anti-ulcer agents - administration & dosage (445) 445
double-blind method (445) 445
antacids - therapeutic use (444) 444
prevention (443) 443
drug administration schedule (438) 438
helicobacter-pylori infection (438) 438
dose-response relationship, drug (435) 435
drugs (435) 435
2-pyridinylmethylsulfinylbenzimidazoles - therapeutic use (429) 429
cancer (427) 427
nonsteroidal antiinflammatory drugs (426) 426
patients (426) 426
gastroesophageal reflux - physiopathology (422) 422
dosage and administration (419) 419
clopidogrel (416) 416
clarithromycin (414) 414
triple therapy (414) 414
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10411) 10411
German (201) 201
Japanese (164) 164
Russian (140) 140
Spanish (133) 133
French (125) 125
Korean (71) 71
Chinese (32) 32
Italian (19) 19
Dutch (18) 18
Hungarian (17) 17
Polish (16) 16
Portuguese (9) 9
Finnish (7) 7
Ukrainian (7) 7
Romanian (6) 6
Czech (5) 5
Danish (5) 5
Swedish (4) 4
Norwegian (3) 3
Bulgarian (1) 1
Croatian (1) 1
Lithuanian (1) 1
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 08/2013, Volume 128, Issue 8, pp. 845 - 853
BACKGROUND—Proton pump inhibitors (PPIs) are gastric acid–suppressing agents widely prescribed for the treatment of gastroesophageal reflux disease... 
dimethylarginine dimethylaminohydrolase | endothelium | proton pump inhibitors | nitric oxide | N,N dimethylarginine | N dimethylarginine | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | ENDOTHELIAL DYSFUNCTION | MYOCARDIAL-INFARCTION | NITRIC-OXIDE SYNTHASE | ACID SUPPRESSION | ADMA | DIMETHYLAMINOHYDROLASE DDAH | PERIPHERAL VASCULAR DISEASE | CORONARY-HEART-DISEASE | STAGE RENAL-DISEASE | ARTERY-DISEASE | Proton Pump Inhibitors - pharmacology | Humans | Esomeprazole - adverse effects | Esomeprazole - pharmacology | Endothelium, Vascular - drug effects | Male | Arginine - analogs & derivatives | Esomeprazole - therapeutic use | Cardiovascular Diseases - epidemiology | Nitric Oxide Synthase Type III - metabolism | Gastroesophageal Reflux - drug therapy | Disease Models, Animal | Amidohydrolases - metabolism | Proton Pump Inhibitors - adverse effects | Cardiovascular Diseases - metabolism | Mice, Inbred C57BL | Risk Factors | Cells, Cultured | Biomarkers - blood | Proton Pump Inhibitors - therapeutic use | Animals | Lansoprazole - adverse effects | Endothelium, Vascular - metabolism | Arginine - blood | Lansoprazole - pharmacology | Endothelium, Vascular - pathology | Mice | Vasodilation - drug effects | Lansoprazole - therapeutic use | Gastroesophageal reflux | Complications and side effects | Usage | Care and treatment | Patient outcomes | Proton pump inhibitors | Cardiovascular diseases | Drug therapy | Health aspects | Risk factors
Journal Article
Circulation, ISSN 0009-7322, 02/2012, Volume 125, Issue 8, pp. 978 - 986
Journal Article
BMJ, ISSN 0959-8138, 01/2008, Volume 336, Issue 7634, pp. 2 - 3
...Proton pump inhibitors are one of the most frequently prescribed classes of drug in the world because they combine a high level of efficacy with low toxicity... 
Proton pumps | Prescription drugs | Dyspepsia | Primary health care | Hospital admissions | Proton pump inhibitors | Editorials | Drug prescriptions | State Medicine | Humans | United Kingdom | Practice Patterns, Physicians | Evidence-Based Medicine | Proton Pump Inhibitors - therapeutic use | Drug Prescriptions
Journal Article
Drug Resistance Updates, ISSN 1368-7646, 2015, Volume 23, pp. 69 - 78
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2009, Volume 101, Issue 4, pp. 714 - 719
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 369, Issue 9573, pp. 1621 - 1626
...) inhibitor or a non-steroidal anti-inflammatory drug (NSAID) with a proton-pump inhibitor (PPI). These two treatments have similar effectiveness, but they are insufficient for protection of patients at very high risk for ulcer bleeding... 
Internal Medicine | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | NSAID | CYCLOOXYGENASE-2 INHIBITORS | ARTHRITIS PATIENTS | NAPROXEN | COMPLICATIONS | HELICOBACTER-PYLORI | PEPTIC-ULCER | CELECOXIB | Pyrazoles - therapeutic use | Humans | Esomeprazole - adverse effects | Male | Secondary Prevention | Osteoarthritis - drug therapy | Esomeprazole - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Female | Drug Therapy, Combination | Pyrazoles - adverse effects | Anti-Ulcer Agents - therapeutic use | Double-Blind Method | Proton Pump Inhibitors | Risk Factors | Anti-Ulcer Agents - adverse effects | Peptic Ulcer Hemorrhage - chemically induced | Treatment Outcome | Celecoxib | Peptic Ulcer Hemorrhage - therapy | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Sulfonamides - adverse effects | Aged | Cyclooxygenase Inhibitors - adverse effects | Cyclooxygenase Inhibitors - therapeutic use | Prevention | Complications and side effects | COX-2 inhibitors | Relapse | Gastrointestinal bleeding | Peptic ulcer | Proton pump inhibitors | Dosage and administration | Drug therapy | Diseases | Drugs | Medical research | Physical examinations | Hospitals | Analgesics | Ulcers | Terminal illnesses | Clinical trials | Pharmaceuticals
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 28 - 35
Journal Article